[{"AccountsPayableCurrent_0_Q3_USD":6170000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-915914000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":158724000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":49823000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":38684000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":5400000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":146550000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":117818000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":18062000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":4826000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":164780000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":1563000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":466000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":101000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-1602000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":258000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":4000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":-4000.0,"OtherAssetsNoncurrent_0_Q3_USD":18778000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":22025000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":4521000.0,"OperatingIncomeLoss_3_Q3_USD":-144559000.0,"OperatingIncomeLoss_1_Q3_USD":-52987000.0,"NetIncomeLoss_3_Q3_USD":-144093000.0,"NetIncomeLoss_1_Q3_USD":-52886000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-89521000.0,"Revenues_1_Q3_USD":15662000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-23056000.0,"Revenues_3_Q3_USD":63300000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":59494836.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":61169754.0,"UnrealizedGainLossOnInvestments_1_Q3_USD":-4000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":19640000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":302649.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":291438000.0,"StockholdersEquity_0_Q3_USD":291438000.0,"StockGrantedDuringPeriodValueSharebasedCompensation_1_Q3_USD":-666000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":20.86,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":19.12,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":17.77,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_3_Q3_USD":14800000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q3_USD":21.62,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":8135407.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q3_USD":18793000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":21.52,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":8530589.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":19925000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":15.21,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_3_Q3_shares":1914846.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":339961.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3_Q3_USD":3200000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":22.76,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":5314252.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":10445000.0,"ShareBasedCompensation_3_Q3_USD":17714000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":121977000.0,"LiabilitiesCurrent_0_Q3_USD":68864000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":392160000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":16314000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-144089000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-52890000.0,"CommonStockValue_0_Q3_USD":613000.0,"CommonStockSharesOutstanding_0_Q3_shares":61254693.0,"CommonStockSharesAuthorized_0_Q3_shares":125000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.01,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":9400000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":190531000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":190531000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":69000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":108367000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":108371000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":7000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":3000.0,"AssetsCurrent_0_Q3_USD":334698000.0,"Assets_0_Q3_USD":392160000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":17714000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":6358000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":6309000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":1206742000.0,"AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0_Q3_USD":-3000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":41859000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-1267000.0,"AccountsReceivableNetCurrent_0_Q3_USD":13759000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":9575000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":1665000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":1704000.0,"CostsAndExpenses_1_Q3_USD":68649000.0,"Liabilities_0_Q3_USD":100722000.0,"Investments_0_Q3_USD":108367000.0,"InventoryWorkInProcess_0_Q3_USD":3095000.0,"InventoryValuationReserves_0_Q3_USD":1600000.0,"InventoryRawMaterials_0_Q3_USD":608000.0,"InventoryNet_0_Q3_USD":3979000.0,"InventoryFinishedGoods_0_Q3_USD":276000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":1080000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":-5146000.0,"IncreaseDecreaseInOtherCurrentLiabilities_3_Q3_USD":258000.0,"IncreaseDecreaseInOperatingLeaseLiability_3_Q3_USD":-2701000.0,"IncreaseDecreaseInInventories_3_Q3_USD":5582000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":61169754.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":14507000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-9322000.0,"IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_3_Q3_USD":-1931000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":47431000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":17161000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":36300000.0,"EarningsPerShareDiluted_3_Q3_USD":-2.42,"EarningsPerShareDiluted_1_Q3_USD":-0.86,"EarningsPerShareBasic_3_Q3_USD":-2.42,"EarningsPerShareBasic_1_Q3_USD":-0.86,"DepreciationDepletionAndAmortization_3_Q3_USD":8306000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q3_USD":0.0,"CostsAndExpenses_3_Q3_USD":207859000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":7744000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":59494836.0,"Ticker":"MGNX","CIK":"1125345","name":"MACROGENICS INC","OfficialName":"MacroGenics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"504089511.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211102"}]